International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 4 July-August 2024 Submit your research before last 3 days of August to publish your research paper in the issue of July-August.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 4
July-August 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

A Review on Invitro Evolution of Glimepiride Tablets

Author(s) Manoj Sarjerao Doiphode, Vikas Bhausaheb Wamne
Country India
Abstract Type 2 diabetes mellitus is characterised via way of means of insulin resistance and innovative β mobileular Failure; therefore, β mobileular secretagogues are beneficial for attaining enough glycemic control. Glimepiride is a second-era sulfonylurea that stimulates pancreatic β cells to launch Insulin. Additionally, is has been proven to paintings thru numerous more pancreatic mechanisms. It Is administered as monotherapy in sufferers with kind 2 diabetes mellitus in whom glycemic Control isn’t executed with the aid of using nutritional and way of life modifications. It also can be mixed with different Antihyperglycemic agents, such as metformin and insulin, in sufferers who aren’t safely Controlled with the aid of using sulfonylureas alone. The powerful dosage variety is 1 to eight mg/day; however, There isn’t any extensive distinction among four and eight mg/day, however it ought to be used with warning In the aged and in sufferers with renal or hepatic ailment. In scientific studies, glimepiride became Generally related to decrease threat of hypoglycemia and much less weight advantage as compared to different sulfonylureas. Glimepiride use can be more secure in sufferers with cardiovascular ailment due to its loss of adverse results on ischemic preconditioning. It is powerful in lowering fasting plasma glucose, post-prandial glucose, and glycosylated hemoglobin tiers and is a useful, cost-powerful remedy alternative for handling kind 2 diabetes mellitus.
Keywords antihyperglycemic agents, diabetes, glimepiride, sulfonylurea, Growth factors,
Field Medical / Pharmacy
Published In Volume 5, Issue 3, May-June 2023
Published On 2023-05-04
Cite This A Review on Invitro Evolution of Glimepiride Tablets - Manoj Sarjerao Doiphode, Vikas Bhausaheb Wamne - IJFMR Volume 5, Issue 3, May-June 2023. DOI 10.36948/ijfmr.2023.v05i03.2845
DOI https://doi.org/10.36948/ijfmr.2023.v05i03.2845
Short DOI https://doi.org/gr7hc9
View / Download PDF File

Share this


E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 4 Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com